Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001460073-10-000002
Filing Date
2010-03-11
Accepted
2010-03-11 09:34:55
Documents
1
Effectiveness Date
2010-03-11
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8794
  Complete submission text file 0001460073-10-000002.txt   10390
Mailing Address c/o Merrill Lynch Alternative Investment 2 World Financial Cntr, 225 Liberty ST, New York NY 10281
Business Address c/o Merrill Lynch Alternative Investment 2 World Financial Cntr, 225 Liberty ST, New York NY 10281
Blackrock Health Sciences Access LLC (Filer) CIK: 0001460073 (see all company filings)

State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-129180 | Film No.: 10672550